Evidence map›Paper›PMID 23575437›Full record

ArticleCNS neuroscience & therapeutics2013

Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings).

Georges Mion, Thierry Villevieille

4 registry-linked trialsOpen access · bronzeAbstract readHistorical Article
In one paragraph

Article in CNS neuroscience & therapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 288 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
288citing papers in PubMed, 11 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02783430 phase2 / phase3completednot on this mapstarted 2016, after this paper: background citation

Evaluation of the Initial Prescription of Ketamine and Milnacipran Forin Depression in Patients With a Progressive Disease

TypeinterventionalSponsorUniversity Hospital, LilleRan2016 to 2024Enrolled42ConditionsDepressionArmsKetamine, Milnacipran, Placebo
NCT03049930 phase4unknown statusnot on this mapstarted 2018, after this paper: background citation

Intraoperative Low-dose Ketamine Infusion as the Main Analgesic in Burn Patients

TypeinterventionalSponsorLoyola UniversityRan2018 to 2020Enrolled46ConditionsBurnsArmsKetamine, Sodium chloride
NCT04260607 phase3terminatednot on this mapstarted 2020, after this paper: background citation

Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department

TypeinterventionalSponsorNaval Medical Center Camp LejeuneRan2020 to 2022Enrolled1ConditionsSuicide, Suicide Threat, Depression SevereArmsKetamine Hydrochloride, Normal saline
NCT05175781 nacompletednot on this mapstarted 2022, after this paper: background citation

Dexmedetomidine Versus Ketamine to Facilitate Non-invasive Ventilation After Blunt Chest Trauma

TypeinterventionalSponsorAswan University HospitalRan2022 to 2022Enrolled45ConditionsChest TraumaArmsDexmedetomidine Hydrochloride, Ketamine Hydrochloride, Placebo
3 · Its place in the literature

Who cites it

288 citing papers in PubMed, 11 syntheses or guidelines pooled it, 661 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Ketamine versus morphine for musculoskeletal trauma pain: a meta-analysis of randomized controlled trials.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2026
    Pooled it
  4. Ketamine and other NMDA receptor antagonists for chronic pain.The Cochrane database of systematic reviews · 2025
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Infusion Therapy in the Treatment of Neuropathic Pain.Current pain and headache reports · 2022
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

228 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Georges MionService d'anesthésie, Pôle Anesthésie Réanimations Thorax Exploration, Groupe hospitalier Cochin-Broca-Hôtel-Dieu, Paris, France. georges.mion@bbox.fr
Thierry Villevieille
Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale · FRHôpital d'Instruction des Armées Bégin · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For more than 50 years, ketamine has proven to be a safe anesthetic drug with potent analgesic properties. The active enantiomer is S(+)-ketamine. Ketamine is mostly metabolized in norketamine, an active metabolite. During "dissociative anesthesia", sensory inputs may reach cortical receiving areas, but fail to be perceived in some association areas. Ketamine also enhances the descending inhibiting serotoninergic pathway and exerts antidepressive effects. Analgesic effects persist for plasma concentrations ten times lower than hypnotic concentrations. Activation of the (N-Methyl-D-Aspartate [NMDA]) receptor plays a fundamental role in long-term potentiation but also in hyperalgesia and opioid-induced hyperalgesia. The antagonism of NMDA receptor is responsible for ketamine's more specific properties. Ketamine decreases the "wind up" phenomenon, and the antagonism is more important if the NMDA channel has been previously opened by the glutamate binding ("use dependence"). Experimentally, ketamine may promote neuronal apoptotic lesions but, in usual clinical practice, it does not induce neurotoxicity. The consequences of high doses, repeatedly administered, are not known. Cognitive disturbances are frequent in chronic users of ketamine, as well as frontal white matter abnormalities. Animal studies suggest that neurodegeneration is a potential long-term risk of anesthetics in neonatal and young pediatric patients.

Indexed as

AnestheticsAnimalsCognitionDose-Response Relationship, DrugHistory, 20th CenturyHistory, 21st CenturyHumansKetamineReceptors, N-Methyl-D-AspartateAnestheticsKetamineReceptors, N-Methyl-D-Aspartate

Identifiers

PMID23575437
PMCPMC6493357
OpenAlexW2108466731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.